FR3053592B1 - Fibrinogene liquide stable - Google Patents
Fibrinogene liquide stable Download PDFInfo
- Publication number
- FR3053592B1 FR3053592B1 FR1656479A FR1656479A FR3053592B1 FR 3053592 B1 FR3053592 B1 FR 3053592B1 FR 1656479 A FR1656479 A FR 1656479A FR 1656479 A FR1656479 A FR 1656479A FR 3053592 B1 FR3053592 B1 FR 3053592B1
- Authority
- FR
- France
- Prior art keywords
- stable liquid
- liquid fibrinogen
- fibrinogen
- stable
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000008946 Fibrinogen Human genes 0.000 title abstract 2
- 108010049003 Fibrinogen Proteins 0.000 title abstract 2
- 229940012952 fibrinogen Drugs 0.000 title abstract 2
- 239000007788 liquid Substances 0.000 title abstract 2
- FBPFZTCFMRRESA-ZXXMMSQZSA-N D-iditol Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-ZXXMMSQZSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/363—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Abstract
L'invention concerne une composition comprenant du fibrinogène stable sous forme liquide.
Priority Applications (16)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1656479A FR3053592B1 (fr) | 2016-07-06 | 2016-07-06 | Fibrinogene liquide stable |
| EP23184855.7A EP4293116A3 (fr) | 2016-07-06 | 2017-07-06 | Fibrinogène liquide stable |
| JP2019500332A JP2019524704A (ja) | 2016-07-06 | 2017-07-06 | 安定な液体フィブリノーゲン |
| CA3028030A CA3028030A1 (fr) | 2016-07-06 | 2017-07-06 | Aptameres anti-fibrinogene et utilisations associees |
| EP17742825.7A EP3481415B1 (fr) | 2016-07-06 | 2017-07-06 | Fibrinogène liquide stable |
| KR1020197003577A KR20190026000A (ko) | 2016-07-06 | 2017-07-06 | 안정적 액체 피브리노겐 |
| PCT/EP2017/066952 WO2018007530A1 (fr) | 2016-07-06 | 2017-07-06 | Aptamères anti-fibrinogène et utilisations associées |
| ES17742825T ES2964819T3 (es) | 2016-07-06 | 2017-07-06 | Fibrinógeno líquido estable |
| CN202410763564.4A CN118697858A (zh) | 2016-07-06 | 2017-07-06 | 稳定的液体纤维蛋白原 |
| EP17740675.8A EP3481957A1 (fr) | 2016-07-06 | 2017-07-06 | Aptamères anti-fibrinogène et utilisations associées |
| PCT/FR2017/051852 WO2018007767A1 (fr) | 2016-07-06 | 2017-07-06 | Fibrinogène liquide stable |
| CN201780054157.4A CN109689088A (zh) | 2016-07-06 | 2017-07-06 | 稳定的液体纤维蛋白原 |
| US16/312,457 US20190316133A1 (en) | 2016-07-06 | 2017-07-06 | Anti-Fibrinogen Aptamers and Uses Thereof |
| CA3029075A CA3029075A1 (fr) | 2016-07-06 | 2017-07-06 | Fibrinogene liquide stable |
| US16/315,388 US20190209659A1 (en) | 2016-07-06 | 2017-07-06 | Stable liquid fibrinogen |
| AU2017292711A AU2017292711A1 (en) | 2016-07-06 | 2017-07-06 | Stable liquid fibrinogen |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1656479A FR3053592B1 (fr) | 2016-07-06 | 2016-07-06 | Fibrinogene liquide stable |
| FR1656479 | 2016-07-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR3053592A1 FR3053592A1 (fr) | 2018-01-12 |
| FR3053592B1 true FR3053592B1 (fr) | 2020-05-29 |
Family
ID=56943767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR1656479A Active FR3053592B1 (fr) | 2016-07-06 | 2016-07-06 | Fibrinogene liquide stable |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR3053592B1 (fr) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10261126A1 (de) * | 2002-08-13 | 2004-03-04 | Aventis Behring Gmbh | Lagerungsstabile, flüssige Fibrinogen-Formulierung |
| FR2857267B1 (fr) * | 2003-07-09 | 2006-03-10 | Lab Francais Du Fractionnement | Formulation stabilisante et solubilisante pour les proteines cryoprecipitables. |
| DE102004009400A1 (de) * | 2004-02-24 | 2005-09-08 | Zlb Behring Gmbh | Fibrinogen Reinigung |
| FR3018450B1 (fr) * | 2014-03-11 | 2016-04-15 | Lab Francais Du Fractionnement | Procede de preparation de proteines plasmatiques humaines |
-
2016
- 2016-07-06 FR FR1656479A patent/FR3053592B1/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| FR3053592A1 (fr) | 2018-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4293116A3 (fr) | Fibrinogène liquide stable | |
| EA201690613A1 (ru) | Улучшенные составы на основе аденовирусов | |
| MX2015009552A (es) | Composiciones que incluyen agentes para conferir caracter hidrofobico y estabilizantes y metodos para elaborar y usar los mismos. | |
| EA201891182A1 (ru) | Стабильные композиции с инокулянтом и способы их получения | |
| PH12018500402B1 (en) | Laundry detergent composition | |
| CL2015002897A1 (es) | Inhibidores de bace1 | |
| UA115373C2 (uk) | Стабільний рідкий склад amg 416 (велкалсетиду) | |
| WO2018104285A3 (fr) | Additifs pour mélanges de cristaux liquides | |
| TR201902741T4 (tr) | Kişisel Temizlik Bileşimleri | |
| EA201791716A1 (ru) | Фармацевтический состав | |
| LT3419595T (lt) | Stabili skysta gonadotropino kompozicija | |
| Adell et al. | Estimates for the moments of Bernstein polynomials | |
| MX377022B (es) | Composiciones de lágrimas artificiales. | |
| WO2016113752A3 (fr) | Formulation liquide de cabazitaxel | |
| MX2021001361A (es) | Composicion liquida de fibrinogeno humano. | |
| MX2019001462A (es) | Composiciones solidas de limpieza con taurina y metodos de estas. | |
| FR3053592B1 (fr) | Fibrinogene liquide stable | |
| BR112015022975A2 (pt) | partículas de resinato de fenilefrina | |
| WO2018200615A3 (fr) | Produits de contraste pour irm modifiés et leurs utilisation | |
| HK1254516A1 (zh) | 包含3-o-棓酰-3，3'，5，5'，7-五羥基黃烷的保濕用組合物 | |
| RU2013155770A (ru) | Средство для коррекции нарушений в легочной ткани при цитостатическом воздействии | |
| MA51185A (fr) | Compositions comprenant des souches bactériennes | |
| RU2012116371A (ru) | Жидкость для глушения скважин | |
| Kru | Kidi-A Na Kru | |
| Kru | Shilpi-A Na Kru |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PLFP | Fee payment |
Year of fee payment: 2 |
|
| PLSC | Publication of the preliminary search report |
Effective date: 20180112 |
|
| PLFP | Fee payment |
Year of fee payment: 3 |
|
| PLFP | Fee payment |
Year of fee payment: 4 |
|
| PLFP | Fee payment |
Year of fee payment: 5 |
|
| PLFP | Fee payment |
Year of fee payment: 6 |
|
| PLFP | Fee payment |
Year of fee payment: 7 |
|
| CA | Change of address |
Effective date: 20221108 |
|
| PLFP | Fee payment |
Year of fee payment: 8 |
|
| PLFP | Fee payment |
Year of fee payment: 9 |